"Serious question to anyone, with only 120 patients needed for this trial, why is there a need to spread it out over multiple sites including overseas! Wouldn’t it be much easier and quicker to focus on just a couple sites given that there is so many patients everywhere!"
I think only the ceo can answer that question. Galera has a phase 2, 50 patient covid trial(intiated on 9/9/20) for their drug GC4419(same drug in OM trials) at 2 trial sites. CT lists primary completion date November 2021 and study completion date as December 2021.